ReviewCancer immunology research2014

Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists.

Michail V Sitkovsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.